-
Juno Therapeutics Inc (NASDAQ: JUNO) shares fell
6.3 percent to touch a new 52-week low of $19.14. Raymond James downgraded Juno Therapeutics from Outperform to Market Perform.
-
PDL BioPharma Inc (NASDAQ: PDLI) shares touched a
new 52-week low of $2.03. PDL BioPharma shares have dropped 42.94 percent over the past 52 weeks, while the S&P 500 index
has gained 6.15 percent in the same period.
-
Coca-Cola European Partners plc (NYSE: CCE) shares
reached a new 52-week low of $31.09. Stifel Nicolaus downgraded Coca-Cola European Partners from Buy to Hold.
-
Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA) shares fell 4.7 percent to reach a new 52-week low of $35.30. Teva named
Dipankar Bhattacharjee as President and Chief Executive Officer, Global Generic Medicines Group. The company announced a
positive outcome for COPAXONE® label in Europe and reaffirmed its 2016 guidance.
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.